CORRECTION FROM SOURCE: KALY Exits Cannabis Business With Shareholder Cannabis Dividend
This document corrects and replaces the press release that was issued by Kali Inc. (OTC Pink: KALY) (“KALY”) today July 16, 2020 at 11:24 am ET. The release below replaces the entirety of the previous release, as the incorrect release was sent.The corrected press release follows in full below:Dallas, Texas--(Newsfile Corp. - July 16, 2020) - Kali, Inc. (OTC Pink: KALY) ("KALY") today announced a deal in the works to sell its cannabis execration subsidiary, NCM Biotech, to PAO Group,...
2020-07-16 12:40 PM EDT
KALY Previews Investment Commitment Into Its Cannabis Biopharmaceutical Technology
Dallas, Texas--(Newsfile Corp. - February 3, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY"), today previewed a Letter of Intent (LOI) executed with a third-party investor. The LOI details are anticipated to be released tomorrow. Management indicates the two-stage investment is of substantial magnitude and can meaningfully advance the company's ongoing development of its cannabis biopharmaceutical technology. KALY has a U.S. Patented Cannabis Extraction Process it uses to produce proprietary formulations for the...
2020-02-03 10:52 AM EST
KALY Patented Cannabis Biotech $50 Million Valuation Supported By Analyst Assessment Of Cannabis Pharmaceuticals Driving $66 Billion Sector
Dallas, Texas--(Newsfile Corp. - January 31, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today pointed to a Grand View Research report on the legal marijuana market projecting the legal marijuana market to reach over $66 Billion in value by 2025 to support a recent $50 Million valuation of KALY's cannabis biotechnology. KALY has U.S. Patented Cannabis Extraction Process it uses to produce proprietary formulations for the treatment of various medical conditions. ...
2020-01-31 10:34 AM EST
KALY- Kali-Extracts Proprietary CBD Extract Could Offer Coronavirus Relief
Dallas, Texas--(Newsfile Corp. - January 29, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today confirmed efforts to evaluate its proprietary CBD extract formulation as a treatment for coronavirus symptoms. KALY's proprietary CBD formulation has been developed for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The formulation for the treatment of symptoms associated with COPD and other similar respiratory conditions has been derived from...
2020-01-29 11:08 AM EST
KALY- Kali-Extracts Enters Negotiations On Agricultural CBD Extraction Spinoff
Dallas, Texas--(Newsfile Corp. - January 24, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today announced entering negotiations on the spinoff of the company's agricultural CBD extraction business. The spinoff is part of KALY's plans to consolidate its business structure and focus on its Cannabis Biopharmaceutical Technology. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions. The technology has been valued at $50 million in...
2020-01-24 12:35 PM EST
KALY Announces Cannabis Biopharmaceutical Technology Business Consolidation
Dallas, Texas--(Newsfile Corp. - January 14, 2020) - Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) ("KALY") today announced plans to consolidate its business structure and focus on its Cannabis Biopharmaceutical Technology. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions. The technology has been valued at $50 million in conjunction with a recent acquisition offer that ALYI management passed on. In reaction to the offer, management has refined...
2020-01-14 10:22 AM EST
KALY to Release $50 Million 2020 Biopharmaceutical Technology Strategy Next Week
Dallas, Texas--(Newsfile Corp. - January 8, 2020) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today announced that management will release its 2020 Cannabis Biopharmaceutical Technology Strategy next week on Tuesday, January 14, 2020. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions. After receiving two inquiries into the acquisition of the company's cannabis biopharmaceutical technology valuing the technology at $50 million, KALY management introduced...
2020-01-08 9:08 AM EST
KALY - Kali-Extracts Announces Reaching $1 Million In Sales
Dallas, Texas--(Newsfile Corp. - December 23, 2019) - Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) ("KALY") today announced that the Company has reached $1 million in sales. Subject to an accounting review of its overall 2019 financials, management anticipates reporting over $1 million in revenue for 2019. The major revenue contribution comes from KALY's first hemp extraction contracts.KALY's revenues through the end of Q3 come primarily from the sale of CBD infused products that have utilized...
2019-12-23 12:42 PM EST
KALY Announces Anchor Investor in Cannabis Biopharmaceutical Technology at $50 Million Valuation
Dallas, Texas--(Newsfile Corp. - December 17, 2019) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today announced an anchor investor in its biopharmaceutical technology. KALY recently announced restructuring its cannabis biopharmaceutical business as part of a strategy to facilitate a strategic investment at a $50 million valuation. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions (see below). After receiving two inquiries into the acquisition of the...
2019-12-17 9:47 AM EST
KALY - Kali-Extracts Expects 2020 Revenue Growth Acceleration from CBD Infused Consumer Products
Dallas, Texas--(Newsfile Corp. - December 11, 2019) - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) ("KALY") today announced expected revenue growth acceleration in 2020 from the sales of CBD infused consumer products. The company currently generates revenue from the sale of CBD infused candies and beverages. KALY produces and sells Hemp4mula chewing gum and gummies available on www.USMJ.com and it has licensed its patented cannabis extraction process for the production of CBD infused beverages. KALY...
2019-12-11 9:34 AM EST
KALY - Kali-Extracts Announces Cannabis Biopharmaceutical Business Restructuring
Dallas, Texas--(Newsfile Corp. - December 10, 2019) - Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) ("KALY") today announced the company is restructuring its cannabis biopharmaceutical business. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions (see below). KALY has recently announced receiving two inquiries into the acquisition of the company's cannabis biopharmaceutical technology valuing the technology at $50 million. KALY management has recently announced that in...
2019-12-10 8:50 AM EST
KALY - Kali-Extracts Proceeds With Capital Infusion Plan At $50 Million Valuation
Dallas, Texas--(Newsfile Corp. - December 6, 2019) - Kali-Extracts, Inc. (OTC Pink: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) ("KALY") today announced it will proceed with a capital infusion plan to accelerate the growth of its cannabis biopharmaceutical technology. KALY has recently announced receiving two inquiries into the acquisition of the company's cannabis biopharmaceutical technology valuing the technology at $50 million. KALY has a U.S. Patented Cannabis Extraction Process and is developing treatments for various medical conditions (see below). ...
2019-12-06 9:25 AM EST